Intrathecal microRNA as a treatment for inherited amyotrophic lateral sclerosis

Phase 3 trial launched to further evaluate the safety and efficacy of AAV-miR-SOD1.
Phase 3 trial launched to further evaluate the safety and efficacy of AAV-miR-SOD1.